Clinical Trials Browser

NIH × Gliosarcoma × Irinotecan × Clear all

NCT00433381 2018-09-17

Bevacizumab and Irinotecan or Temozolomide in Treating Patients With Recurrent or Refractory Glioblastoma Multiforme or Gliosarcoma

Phase 2 Completed

123 enrolled 16 charts

Brain Neoplasms, Glioblastoma, Gliosarcoma

NCT00003301 2013-06-21

Irinotecan in Treating Patients With Recurrent Malignant Glioma

Phase 1/2 Completed

Astrocytoma, Brain Neoplasms, Glioblastoma, Central Nervous System Neoplasms, Gliosarcoma